Targeting STAT3 Signaling Facilitates Responsiveness of Pancreatic Cancer Cells to Chemoradiotherapy

SIMPLE SUMMARY: Preoperative chemoradiotherapy (CRT) has emerged as a potential therapeutic strategy to increase the fraction of patients with pancreatic ductal adenocarcinoma (PDAC) who are candidates for surgical resection. However, treatment response is heterogeneous and ranges from complete resp...

Descripción completa

Detalles Bibliográficos
Autores principales: Flebbe, Hannah, Spitzner, Melanie, Marquet, Philipp Enno, Gaedcke, Jochen, Ghadimi, B. Michael, Rieken, Stefan, Schneider, Günter, Koenig, Alexander O., Grade, Marian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908974/
https://www.ncbi.nlm.nih.gov/pubmed/35267609
http://dx.doi.org/10.3390/cancers14051301

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908974/
https://www.ncbi.nlm.nih.gov/pubmed/35267609
http://dx.doi.org/10.3390/cancers14051301

Ejemplares similares